On 2025-05-14, Adial Pharmaceuticals, Inc. (ADIL) announced earnings per share of $-0.34 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.50.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.25 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.50 | $-0.34 |
| 2025-03-04 | 2024-12-31 | $-0.38 | $-0.15 |
| 2024-11-13 | 2024-09-30 | $-0.50 | $-0.38 |
| 2024-08-13 | 2024-06-30 | $-0.39 | $-0.59 |
| 2024-05-14 | 2024-03-31 | $-0.51 | $-0.68 |
| 2023-11-14 | 2023-09-30 | $-1.14 | $-1.14 |
| 2023-08-21 | 2023-06-30 | $-1.50 | $-1.33 |
| 2023-05-12 | 2023-03-31 | $-3.50 | $-2.75 |
| 2023-03-30 | 2022-12-31 | $-3.75 | $-2.75 |
| 2022-11-14 | 2022-09-30 | $-4.50 | $-3.00 |
| 2022-08-16 | 2022-06-30 | $-4.00 | $-4.00 |
| 2022-05-16 | 2022-03-31 | $-4.25 | $-3.25 |
| 2022-03-28 | 2021-12-31 | -- | $-7.00 |
| 2021-11-15 | 2021-09-30 | $-5.50 | $-5.50 |
| 2021-08-12 | 2021-06-30 | -- | $-6.25 |
| 2021-05-17 | 2021-03-31 | -- | $-7.50 |
| 2021-03-22 | 2020-12-31 | -- | $-6.00 |
| 2020-11-13 | 2020-09-30 | -- | $-6.00 |
| 2020-08-13 | 2020-06-30 | -- | $-4.00 |
| 2020-05-14 | 2020-03-31 | -- | $-5.50 |
| 2020-03-20 | 2019-12-31 | -- | $-4.75 |
| 2019-11-14 | 2019-09-30 | -- | $-4.25 |
| 2019-08-13 | 2019-06-30 | -- | $-5.25 |
| 2019-05-13 | 2019-03-31 | -- | $-8.25 |
| 2018-11-14 | 2018-09-30 | $-7.75 | $-21.25 |
| 2018-09-07 | 2018-06-30 | -- | $-12.50 |